$ACTG
ACACIA RESEARCH CORP Stock $actg

$actg Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000093454922000079 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$13.12M	$15.88M	$1.582M
YoY Change	-79.26%	903.67%	-91.87%
Cost Of Revenue	$9.611M	$9.930M	$280.0K
YoY Change	21.26%	3446.43%	-95.15%
Gross Profit	$3.510M	$5.948M	$1.302M
YoY Change	-93.66%	356.84%	-90.49%
Gross Profit Margin	26.75%	37.46%	82.3%
Selling, General & Admin	$18.06M	$17.16M	$10.63M
YoY Change	-12.03%	61.4%	-25.66%
% of Gross Profit	514.5%	288.45%	816.44%
Research & Development		$156.0K	$0.00
YoY Change
% of Gross Profit		2.62%	0.0%
Depreciation & Amortization	$3.374M	$3.363M	$2.651M
YoY Change	-68.43%	26.86%	120.92%
% of Gross Profit	96.13%	56.54%	203.61%
Operating Expenses	$18.06M	$17.31M	$13.24M
YoY Change	-23.01%	30.74%	-14.46%
Operating Profit	-$14.55M	-$11.37M	-$11.94M
YoY Change	-145.64%	-4.82%	567.04%
Interest Expense	-$5.842M	$40.44M	$102.3M
YoY Change	-102.96%	-60.48%	148.33%
% of Operating Profit
Other Income/Expense, Net		$40.44M	$102.5M
YoY Change		-60.54%
Pretax Income	-$20.39M	$29.08M	$89.62M
YoY Change	-108.92%	-67.56%	133.19%
Income Tax	-$1.812M	$679.0K	$11.00K
% Of Pretax Income		2.34%	0.01%
Net Earnings	-$20.53M	$28.09M	$89.60M
YoY Change	-110.03%	-68.65%	133.65%
Net Earnings / Revenue	-156.45%	176.91%	5663.97%
Basic Earnings Per Share		$0.54	$1.49
Diluted Earnings Per Share	-$0.50	$0.02	$962.6K
COMMON SHARES
Basic Shares Outstanding	43.54M shares	38.31M shares	48.95M shares
Diluted Shares Outstanding		71.16M shares	93.08M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$386.1M	$401.2M	$642.7M
YoY Change	-45.42%	-37.58%	112.12%
Cash & Equivalents	$287.8M	$241.9M	$218.0M
Short-Term Investments	$98.36M	$159.3M	$424.8M
Other Short-Term Assets	$19.39M	$5.173M	$4.747M
YoY Change	306.97%	8.97%	-92.44%
Inventory	$14.22M	$13.80M
Prepaid Expenses
Receivables	$8.231M	$7.040M	$412.0K
Other Receivables	$0.00	$0.00	$21.54M
Total Short-Term Assets	$428.0M	$427.2M	$669.4M
YoY Change	-41.43%	-36.19%	82.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.537M	$3.700M	$671.0K
YoY Change	-15.44%	451.42%	-39.0%
Goodwill	$7.541M	$7.470M
YoY Change	0.95%
Intangibles	$36.66M	$39.69M
YoY Change	-24.87%
Long-Term Investments	$30.93M	$72.11M
YoY Change	0.0%
Other Assets	$5.202M	$4.819M	$728.0K
YoY Change	-1.53%	561.95%	-98.19%
Total Long-Term Assets	$54.94M	$58.07M	$76.65M
YoY Change	-19.41%	-24.23%	26.9%
TOTAL ASSETS
Total Short-Term Assets	$428.0M	$427.2M	$669.4M
Total Long-Term Assets	$54.94M	$58.07M	$76.65M
Total Assets	$482.9M	$485.3M	$746.1M
YoY Change	-39.55%	-34.96%	74.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.036M	$5.097M	$2.196M
YoY Change	10.96%	132.1%	-18.67%
Accrued Expenses	$18.80M	$14.33M	$17.61M
YoY Change	99.54%	-18.61%	577.12%
Deferred Revenue	$1.229M	$1.403M
YoY Change	10.32%
Short-Term Debt	$60.45M	$61.35M	$182.9M
YoY Change	-66.65%	-66.45%	60.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$87.21M	$85.44M	$204.4M
YoY Change	-56.44%	-58.21%	47.83%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.675M	$1.781M	$295.8M
YoY Change	-72.81%	-99.4%	290.29%
Total Long-Term Liabilities	$1.675M	$1.781M	$295.8M
YoY Change	-72.81%	-99.4%	290.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$87.21M	$85.44M	$204.4M
Total Long-Term Liabilities	$1.675M	$1.781M	$295.8M
Total Liabilities	$193.7M	$184.3M	$512.2M
YoY Change	-45.23%	-64.02%	137.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$306.8M	-$288.4M	-$386.0M
YoY Change	68.82%	-25.28%
Common Stock	$43.00K	$38.00K
YoY Change	-12.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$98.26M	$98.26M
YoY Change	107.82%
Treasury Stock Shares	16.18M shares	16.18M shares
Shareholders Equity	$258.3M	$257.7M	$237.6M
YoY Change
Total Liabilities & Shareholders Equity	$482.9M	$485.3M	$749.8M
YoY Change	-39.55%	-35.28%	75.81%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$20.53M	$28.09M	$89.60M
YoY Change	-110.03%	-68.65%	133.65%
Depreciation, Depletion And Amortization	$3.374M	$3.363M	$2.651M
YoY Change	-68.43%	26.86%	120.92%
Cash From Operating Activities	-$23.74M	$3.955M	-$1.405M
YoY Change	-213.43%	-381.49%	-111.15%
INVESTING ACTIVITIES
Capital Expenditures	$180.0K	-$142.0K	-$2.022M
YoY Change	-102.24%	-92.98%	1922.0%
Acquisitions
YoY Change
Other Investing Activities	$60.39M	$45.85M	$661.0K
YoY Change	28.51%	6836.16%	-96.85%
Cash From Investing Activities	$60.21M	$45.71M	-$1.361M
YoY Change	54.51%	-3458.27%	-106.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	8.470M	-68.20M	34.85M
YoY Change	-281.02%	-295.71%	-8811.5%
NET CHANGE
Cash From Operating Activities	-23.74M	3.955M	-1.405M
Cash From Investing Activities	60.21M	45.71M	-1.361M
Cash From Financing Activities	8.470M	-68.20M	34.85M
Net Change In Cash	44.94M	-18.54M	32.08M
YoY Change	-18.61%	-157.78%	-3.66%
FREE CASH FLOW
Cash From Operating Activities	-$23.74M	$3.955M	-$1.405M
Capital Expenditures	$180.0K	-$142.0K	-$2.022M
Free Cash Flow	-$23.92M	$4.097M	$617.0K
YoY Change	-182.61%	564.02%	-95.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Registrant Name EntityRegistrantName	Acacia Research Corporation
	dei	Entity Central Index Key EntityCentralIndexKey	0000934549
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndOtherAccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountsPayableAndOtherAccruedLiabilitiesCurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-37721
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4405754
	dei	Entity Address Address Line1 EntityAddressAddressLine1	767 Third Avenue,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	6th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10017
	dei	City Area Code CityAreaCode	332
	dei	Local Phone Number LocalPhoneNumber	236-8500
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	ACTG
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	43540276	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	241874000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	308943000	usd
CY2022Q3	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	81384000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	361778000	usd
CY2022Q3	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2022Q3	actg	Equity Method Investments Current EquityMethodInvestmentsCurrent	72106000	usd
CY2021Q4	actg	Equity Method Investments Current EquityMethodInvestmentsCurrent	30934000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7040000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9517000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	13802000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8930000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5173000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4764000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	427195000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	730682000	usd
CY2022Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	0	usd
CY2021Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	418000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3700000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4183000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7470000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7470000	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39692000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	48793000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2393000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2027000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4819000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5283000	usd
CY2022Q3	us-gaap	Assets Assets	485269000	usd
CY2021Q4	us-gaap	Assets Assets	798856000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5097000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5440000	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9258000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6227000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5070000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3698000	usd
CY2022Q3	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	3259000	usd
CY2021Q4	actg	Royalties And Contingent Legal Fees Payable RoyaltiesAndContingentLegalFeesPayable	2463000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1403000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1114000	usd
CY2022Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	61350000	usd
CY2021Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	181248000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	85437000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	200190000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	665000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	581000	usd
CY2022Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9396000	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	11291000	usd
CY2022Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	22389000	usd
CY2021Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	18448000	usd
CY2022Q3	actg	Embedded Derivative Fair Value Of Embedded Derivative Liability1 EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1	59742000	usd
CY2021Q4	actg	Embedded Derivative Fair Value Of Embedded Derivative Liability1 EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability1	96378000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2186000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2027000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2710000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18552000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1781000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6161000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	184306000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	353628000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	18482000	usd
CY2021Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	14753000	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38540276	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38540276	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48807748	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	48807748	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	38000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	49000	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	16183703	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	5388469	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	98258000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	47281000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	644329000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	648389000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-288403000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181724000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	257706000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	419433000	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	24775000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	11042000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	282481000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	485269000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	798856000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15878000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1582000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46102000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24785000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	156000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	491000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2119000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	0	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6429000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	0	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15038000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10345000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36813000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23014000	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	27243000	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	14304000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	71645000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	41539000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11365000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12722000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25543000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-16754000	usd
CY2022Q3	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-36352000	usd
CY2021Q3	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	66502000	usd
	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-266202000	usd
	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	115509000	usd
CY2022Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	36060000	usd
CY2021Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	37688000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	114434000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	53124000	usd
CY2022Q3	actg	Earnings On Equity Investment In Joint Venture EarningsOnEquityInvestmentInJointVenture	850000	usd
CY2021Q3	actg	Earnings On Equity Investment In Joint Venture EarningsOnEquityInvestmentInJointVenture	0	usd
	actg	Earnings On Equity Investment In Joint Venture EarningsOnEquityInvestmentInJointVenture	42935000	usd
	actg	Earnings On Equity Investment In Joint Venture EarningsOnEquityInvestmentInJointVenture	2737000	usd
CY2022Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	558000	usd
CY2021Q3	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	104190000	usd
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-108833000	usd
	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	171370000	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2752000	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
CY2021Q3	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3591000	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	41638000	usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	619000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	34590000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-203866000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1905000	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-17000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4532000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-193000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1072000	usd
CY2021Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	2378000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	5532000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	5142000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1221000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	76000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3091000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40440000	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	102490000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-81216000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-36857000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29075000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	89768000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-106759000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-53611000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	679000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-14399000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	531000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	28396000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	89757000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-92360000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-54142000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	306000	usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14319000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	906000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	28090000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	89757000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-106679000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-55048000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20587000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	73110000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-112507000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-58595000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38052426	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48949504	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42830700	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48759873	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	42830700	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	48759873	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1531000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	80308000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-112507000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-58595000	usd
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	71164236	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	93081502	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	268174000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	28396000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	1337000	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	700000	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1017000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1031000	usd
CY2022Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11480000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	282481000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	143196000	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	89757000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	991000	usd
CY2021Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	262000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	108000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	300000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	232108000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	430475000	usd
	us-gaap	Profit Loss ProfitLoss	-92360000	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	586000	usd
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	3729000	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	2099000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1520000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3288000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	50988000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	282481000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	288316000	usd
	us-gaap	Profit Loss ProfitLoss	-54142000	usd
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2762000	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	785000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	202000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1279000	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	232108000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-92360000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-54142000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1000	usd
	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	-3941000	usd
	actg	Change In Fair Value Of Series Redeemable Convertible Preferred Stock Embedded Derivative ChangeInFairValueOfSeriesRedeemableConvertiblePreferredStockEmbeddedDerivative	-14683000	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	0	usd
	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-2752000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3591000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10140000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7198000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	90000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1895000	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-11887000	usd
	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	36636000	usd
	actg	Unrealized Gain Loss On Derivatives1 UnrealizedGainLossOnDerivatives1	-177296000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3288000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1279000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-4530000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-193000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-266202000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	115509000	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	114434000	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	53124000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	42935000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	2737000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-15971000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2242000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-94000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4872000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1078000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2191000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4984000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7002000	usd
	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	795000	usd
	actg	Increase Decrease In Royalties And Contingent Legal Fees Payable IncreaseDecreaseInRoyaltiesAndContingentLegalFeesPayable	-369000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	371000	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13598000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9278000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5000000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	13000000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	3591000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	107537000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	57978000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	236164000	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	64235000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	1178000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	1830000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	552000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	115000000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	506000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	67000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	124253000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1389000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50988000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	120000000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	50000000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	2099000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	785000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1520000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	202000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-174607000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64417000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	822000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3535000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-154000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-67487000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	53596000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	309361000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	200546000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241874000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	254142000	usd
	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest	5431000	usd
	us-gaap	Increase Decrease In Prepaid Interest IncreaseDecreaseInPrepaidInterest	2340000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	209000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9000	usd
	actg	Patent Acquisition In Exchange Of Notes Receivable PatentAcquisitionInExchangeOfNotesReceivable	0	usd
	actg	Patent Acquisition In Exchange Of Notes Receivable PatentAcquisitionInExchangeOfNotesReceivable	4000000	usd
	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	0	usd
	actg	Patent Acquisition Accrued Liability Long Term PatentAcquisitionAccruedLiabilityLongTerm	13000000	usd
	actg	Distribution To Noncontrolling Interests In Subsidiaries DistributionToNoncontrollingInterestsInSubsidiaries	586000	usd
	actg	Distribution To Noncontrolling Interests In Subsidiaries DistributionToNoncontrollingInterestsInSubsidiaries	906000	usd
	actg	Number Of Patent Portfolios Acquired NumberOfPatentPortfoliosAcquired	0	patent
CY2021	actg	Number Of Patent Portfolios Acquired NumberOfPatentPortfoliosAcquired	1	patent
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts in the consolidated financial statements have been reclassified to conform to the current period presentation. These changes had no impact on the previously reported consolidated results of operations or cash flows.</span></div>
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Acacia believes that, of the significant accounting policies described herein, the accounting policies associated with revenue recognition, estimates of variable consideration for revenue, including sales returns, the valuation of equity securities without readily determinable fair value, the determination of excess and obsolete inventories, bad debt allowances and product warranty liabilities, the valuation of Series A redeemable convertible preferred stock (the “Series A Redeemable Convertible Preferred Stock”), embedded derivatives, Series A warrants (the “Series A Warrants”) and Series B warrants (the “Series B Warrants”), stock-based compensation expense, impairment of goodwill, patent-related and other intangible assets, the determination of the economic useful life of amortizable intangible assets, and income taxes and valuation allowances against net deferred tax assets, require its most difficult, subjective or complex judgments.</span></div>
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	111000	usd
	us-gaap	Product Warranty Expense ProductWarrantyExpense	23000	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	772000	usd
CY2022Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P2Y
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	222000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	134000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk are cash equivalents and accounts receivable. The Company places its cash equivalents primarily in highly rated money market funds and investment grade marketable securities. Cash and cash equivalents are also invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. The Company has not experienced any significant losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual Property Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two licensees individually accounted for 47% each of revenues recognized during the three months ended September 30, 2022. Four licensees individually accounted for more than 10% of total recognized revenue, ranging from 13% to 32%, during the three months ended September 30, 2021. Three licensee individually accounted for 18%, 18% and 31% of revenues recognized during the nine months ended September 30, 2022. Three licensees individually accounted for 50%, 19% and 12% of revenues recognized during the nine months ended September 30, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, ARG has not had material foreign operations. Based on the jurisdiction of the entity obligated to satisfy payment obligations pursuant to the applicable license revenue arrangement, for the three and nine months ended September 30, 2022, approximately zero percent and 4%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. For the three and nine months ended September 30, 2021, 8% and 15%, respectively, of revenues were attributable to licensees domiciled in foreign jurisdictions. Refer to Note 15 for additional information regarding revenue from customers by geographic region.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two licensees individually represented approximately 53% and 47% of accounts receivable at September 30, 2022. Two licensees individually represented approximately 59% and 41% of accounts receivable at December 31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industrial Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Printronix customer accounted for more than 10% of revenue for the three and nine months ended September 30, 2022. Printronix has significant foreign operations, refer to Note 15 for additional information regarding net sales to customers by geographic region.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single Printronix customer represented 10% or more of accounts receivable as of September 30, 2022, and one customer represented 11% of accounts receivable as of December 31, 2021. Exposure to credit risk is limited by the large number of customers comprising the remainder of the Printronix customer base and by periodic customer credit evaluations performed by Printronix.</span></div>No single Printronix vendor accounted for 10% or more of purchases for the three and nine months ended September 30, 2022. Accounts payable to two vendors represented 12% and 10% of accounts payable as of September 30, 2022, and one vendor represented 14% of accounts payable as of December 31, 2021.
CY2022Q3	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	85666000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	19240000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	23522000	usd
CY2022Q3	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	81384000	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	99859000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain EquitySecuritiesFvNiUnrealizedGain	264879000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Loss EquitySecuritiesFvNiUnrealizedLoss	2960000	usd
CY2021Q4	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	361778000	usd
	us-gaap	Derivatives Embedded Derivatives DerivativesEmbeddedDerivatives	Embedded DerivativesEmbedded derivatives that are required to be bifurcated from their host contract are valued separately from the host instrument. A binomial lattice framework is used to estimate the fair value of the embedded derivative in the Series A Redeemable Convertible Preferred Stock issued by the Company in 2019.
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.13
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.01
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	887000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	887000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	887000	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	70000	usd
	us-gaap	Interest Income Other InterestIncomeOther	221000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7095000	usd
CY2022Q3	us-gaap	Interest Receivable InterestReceivable	1200000	usd
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	2950000	gbp
CY2021Q4	us-gaap	Notes Receivable Related Parties NotesReceivableRelatedParties	4000000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	4244000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3207000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2944000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1712000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4011000	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	14283000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	8930000	usd
CY2022Q3	us-gaap	Inventory Adjustments InventoryAdjustments	481000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	0	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	13802000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	8930000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5141000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4761000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	1000000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	112000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1441000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	578000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3700000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4183000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	329000	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	39000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7470000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q3	us-gaap	Goodwill Goodwill	7470000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343533000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	303841000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	39692000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	343533000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	294740000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	48793000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3000000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2600000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7100000	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	usd
	actg	Accelerated Amortization Of Patents AcceleratedAmortizationOfPatents	0	usd
	actg	Finite Lived Intangible Assets Write Offs FiniteLivedIntangibleAssetsWriteOffs	35000000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3035000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	12068000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10692000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	8348000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2483000	usd
CY2022Q3	actg	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	3066000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	39692000	usd
CY2021Q4	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	5000000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4500000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	usd
CY2022Q3	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	1290000	usd
CY2021Q4	actg	Accrued Consulting And Other Professional Fees AccruedConsultingAndOtherProfessionalFees	438000	usd
CY2022Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	0	usd
CY2021Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	3000000	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	681000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	42000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	84000	usd
CY2022Q3	actg	Service Contract Costs Accrued Current ServiceContractCostsAccruedCurrent	416000	usd
CY2021Q4	actg	Service Contract Costs Accrued Current ServiceContractCostsAccruedCurrent	307000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1556000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	935000	usd
CY2022Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	773000	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	957000	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9258000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	6227000	usd
CY2021Q3	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	usd
CY2021Q4	actg	Debt Instrument Required Minimum Amount Held In Escrow DebtInstrumentRequiredMinimumAmountHeldInEscrow	35000000	usd
CY2021Q4	actg	Number Of Board Of Directors NumberOfBoardOfDirectors	6	director
CY2022Q3	actg	Number Of Board Of Directors NumberOfBoardOfDirectors	7	director
CY2022Q3	actg	Number Of Additional Directors NumberOfAdditionalDirectors	2	director
CY2022Q3	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2022Q3	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2022Q3	actg	Recapitalization Agreement Blocker Provision Percent RecapitalizationAgreementBlockerProvisionPercent	0.0489
CY2022Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-1200000	usd
CY2021Q3	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-37000000.0	usd
	us-gaap	Legal Fees LegalFees	46000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	408000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	474000	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	155000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1300000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	457000	usd
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	3125819	shares
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	371000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1513000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1123000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	445000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	232000	usd
CY2022Q3	actg	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	58000	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3742000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1556000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2186000	usd
CY2022Q1	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	1200000	usd
	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	0	usd
CY2022Q3	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	0	usd
CY2021Q3	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	0	usd
	actg	Net Income For Settlement Offset By Contingency Accruals NetIncomeForSettlementOffsetByContingencyAccruals	338000	usd
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	40000000	usd
	actg	Beneficial Ownership Maximum Ownership Allowed Percentage BeneficialOwnershipMaximumOwnershipAllowedPercentage	0.049
	actg	Beneficial Ownership Maximum Ownership Allowed Percentage BeneficialOwnershipMaximumOwnershipAllowedPercentage	0.049
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P1Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
	actg	Ownership Percent Of Voting Stock OwnershipPercentOfVotingStock	0.10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1155000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	518000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1155000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.19
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	235000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6700000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P5Y
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	28090000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	89757000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-106679000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-55048000	usd
CY2022Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	700000	usd
CY2021Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	262000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2099000	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	785000	usd
CY2022Q3	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	1337000	usd
CY2021Q3	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	991000	usd
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	3729000	usd
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	2762000	usd
CY2022Q3	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	5466000	usd
CY2021Q3	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	15394000	usd
	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Continuing Operation Earnings Loss Allocation To Participating Securities Basic UndistributedContinuingOperationEarningsLossAllocationToParticipatingSecuritiesBasic	0	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20587000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	73110000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-112507000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-58595000	usd
CY2022Q3	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	3389000	usd
CY2021Q3	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	-63000	usd
	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	0	usd
	actg	Change In Fair Value Of Series A Warrants ChangeInFairValueOfSeriesAWarrants	0	usd
CY2022Q3	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	21766000	usd
CY2021Q3	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	902000	usd
	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	0	usd
	actg	Change In Fair Value Of Dilutive Series B Warrants ChangeInFairValueOfDilutiveSeriesBWarrants	0	usd
CY2022Q3	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	850000	usd
CY2021Q3	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	1536000	usd
	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	0	usd
	actg	Interest Expense Associated With Starboard Notes Net Of Tax InterestExpenseAssociatedWithStarboardNotesNetOfTax	0	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5466000	usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	15394000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	217000	usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	8893000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1531000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	80308000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-112507000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-58595000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38052426	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48949504	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42830700	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48759873	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71164236	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	93081502	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42830700	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48759873	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.20
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.20
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	69520233	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	398168	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	108217890	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	107230624	shares
CY2022Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15878000	usd
CY2022Q3	us-gaap	Royalty Expense RoyaltyExpense	732000	usd
CY2022Q3	actg	Contingent Legal Fees ContingentLegalFees	1010000	usd
CY2022Q3	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	939000	usd
CY2022Q3	actg	Amortization Of Patents AmortizationOfPatents	2601000	usd
CY2022Q3	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	4648000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	9930000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	5948000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11365000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40440000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29075000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10300000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46102000	usd
	us-gaap	Royalty Expense RoyaltyExpense	1092000	usd
	actg	Contingent Legal Fees ContingentLegalFees	2314000	usd
	actg	Litigation And Licensing Expenses Patents LitigationAndLicensingExpensesPatents	3272000	usd
	actg	Amortization Of Patents AmortizationOfPatents	7802000	usd
	us-gaap	Cost Of Other Property Operating Expense CostOfOtherPropertyOperatingExpense	13432000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	27912000	usd
	us-gaap	Gross Profit GrossProfit	18190000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-25543000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-81216000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-106759000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23000000	usd
CY2022Q3	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	81384000	usd
CY2021Q4	actg	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	361778000	usd
CY2022Q3	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2021Q4	us-gaap	Trading Securities Debt TradingSecuritiesDebt	5816000	usd
CY2022Q3	us-gaap	Equity Method Investments EquityMethodInvestments	72106000	usd
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	30934000	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	159306000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	398528000	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	103602000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	172726000	usd
CY2022Q3	us-gaap	Assets Assets	485269000	usd
CY2021Q4	us-gaap	Assets Assets	798856000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15878000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46102000	usd
CY2022Q3	us-gaap	Noncurrent Assets NoncurrentAssets	3700000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	4183000	usd

Files In Submission

Name	View Source	Status
0000934549-22-000079-index-headers.html	Edgar Link	pending
0000934549-22-000079-index.html	Edgar Link	pending
0000934549-22-000079.txt	Edgar Link	pending
0000934549-22-000079-xbrl.zip	Edgar Link	pending
actg-20220930.htm	Edgar Link	pending
actg-20220930.xsd	Edgar Link	pending
actg-2022930xex311.htm	Edgar Link	pending
actg-2022930xex312.htm	Edgar Link	pending
actg-2022930xex321.htm	Edgar Link	pending
actg-2022930xex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
actg-20220930_def.xml	Edgar Link	unprocessable
actg-20220930_lab.xml	Edgar Link	unprocessable
actg-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
actg-20220930_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
actg-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACTG
ACACIA RESEARCH CORP Stock $actg

2022 Q4 Form 10-Q Financial Statement

#000093454922000079 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG ACACIA RESEARCH CORP Stock $actg

2022 Q4 Form 10-Q Financial Statement

#000093454922000079 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACTG
ACACIA RESEARCH CORP Stock $actg